Sign Out
Cytarabine Injection is contraindicated in those patients who are hypersensitive to cytarabine or to any of the excipients.
Anaemia, leucopenia and thrombocytopenia of non-malignant aetiology (e.g. bone marrow aplasia), unless the benefits outweigh the risk.
Degenerative and toxic encephalopathies, especially after the use of methotrexate or treatment with ionizing radiation.
During pregnancy, cytarabine should only be administrated on strict indication, where the benefits of the drug to the mother should be weighed against possible hazards to the fetus.
